MedTrace Logo

Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world Conditions

NCT07052396 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2025-12-22

No results posted yet for this study

Summary

Study to evaluate the change of health-related quality of life, patient characteristics, efficacy and safety in Chronic Obstructive Pulmonary Disease (COPD) patients with Dupilumab therapy in a real-world setting over 24 months.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Dupilumab

This study will not administer any treatment, only observe the treatment as prescribed in real world clinical practice.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2029-07-01
Completion
2029-07-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07052396 on ClinicalTrials.gov